Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer.
about
Association between single nucleotide polymorphisms (SNPs) and toxicity of advanced non-small-cell lung cancer patients treated with chemotherapy.Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers.Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma.MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer.Basic principles and technologies for deciphering the genetic map of cancer.Polymorphisms and a haplotype in heparanase gene associations with the progression and prognosis of gastric cancer in a northern Chinese population.Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis.Predictive effect of XPA and XPD polymorphisms on survival of advanced NSCLC patients treated with platinum-based chemotherapy: a three-dimensional (3-D), polyacrylamide gel-based DNA microarray method.Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy.New take on comparative immunology: relevance to immunotherapy.Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy.The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond.Association between polymorphisms in XRCC1 gene and treatment outcomes of patients with advanced gastric cancer: a systematic review and meta-analysis.Predictive value of XPG rs2296147T>C polymorphism on clinical outcomes of cancer patients.Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.Whole cancer genome sequencing by next-generation methods.Genetic variation and gastric cancer risk: a field synopsis and meta-analysis.Characterization of single-nucleotide polymorphisms relevant to inflammatory bowel disease in commonly used gastrointestinal cell lines.Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.Detection of mosaicism for the polymorphic variants in the 5'-UTR of hOGG1 by cloning and sequence analysis and pyrosequencing.A novel amplification strategy for genotyping with liquid chromatography-electrospray ionization mass spectrometry.Real time hybridization studies by resonant waveguide gratings using nanopattern imaging for Single Nucleotide Polymorphism detection.Genetic association between ERCC5 rs17655 polymorphism and lung cancer risk: evidence based on a meta-analysis.[Research progress of lung cancer on single nuleotide polymorphism].Association between XRCC1 single-nucleotide polymorphisms and susceptibility to nasopharyngeal carcinoma: An update meta-analysis
P2860
Q31106049-27D97E8D-CAD6-4132-8781-B7D33C76062FQ33288464-4AA82FA9-FAF9-4F29-A68E-B4DA278C8FA8Q33518016-040E55F0-7048-42FF-BA19-90592265C31BQ33554403-0B34BF5A-C6D9-4024-98BA-F25EB5961D60Q34074628-B98784AF-EAA5-4108-B31B-045C5EF43E77Q34140460-A1590C55-2478-49A3-933D-1777D98C5F9FQ34160411-D4E85158-2276-4200-9404-399364632DECQ34686858-8FFCBFE0-F832-4F4D-9A37-BF9AD9F26042Q34742602-E5D00674-E2DE-42F2-847D-B5943FED5E53Q36126352-E9E53E3B-CE0F-4630-9986-38C02065640EQ36301463-4EA510FE-C3C6-4473-810F-F3A153E2CF70Q36861133-5E26275A-2749-48F3-BFEA-C921A70B7B9FQ37499473-A9892F2D-FC16-4571-8049-5EBD955FCD0AQ37662309-C6545133-443C-4FA2-83E2-B9B9B8A307D9Q37886990-82B0C226-5724-4556-8BED-735C7E44DF82Q37932206-1EBFDD33-8384-4227-B277-A1E0501BFE5DQ38366774-6D5DE084-9847-44AA-BB2A-62AB02634AE9Q39816980-91A78A4B-1865-4B1B-8142-32E350BA21F4Q43595675-DD284495-57EB-4065-A983-8F4A4741409CQ43833692-86368148-25F4-4AA5-984D-990F2978375AQ44434721-2A027676-C8C1-4CAE-A4B6-A015CCBD08F5Q45212995-BAD0DC7D-508F-40CA-85A1-BE102B5BDD94Q46957223-3428AF4D-56C6-4FE5-829C-80828D7018A5Q53138063-AD816544-664D-43D0-9195-2BC70BF3B0BAQ55464618-13756F21-5FE1-4273-9693-E102582B7505Q58788967-E8011077-2532-435A-B36A-DB35C152137D
P2860
Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Challenges of SNP genotyping a ...... nosis and treatment of cancer.
@ast
Challenges of SNP genotyping a ...... nosis and treatment of cancer.
@en
type
label
Challenges of SNP genotyping a ...... nosis and treatment of cancer.
@ast
Challenges of SNP genotyping a ...... nosis and treatment of cancer.
@en
prefLabel
Challenges of SNP genotyping a ...... nosis and treatment of cancer.
@ast
Challenges of SNP genotyping a ...... nosis and treatment of cancer.
@en
P2860
P356
P1476
Challenges of SNP genotyping a ...... nosis and treatment of cancer.
@en
P2093
Toralf Bernig
P2860
P304
P356
10.1586/14737159.6.3.319
P577
2006-05-01T00:00:00Z